Introduction Alzheimer's disease (AD) is the main cause of dementia and represents a huge
burden for patients, carers, and healthcare systems. Extensive efforts for over 20 years have …

Alzheimer's Disease (AD) is an irreversible and progressive neurological disease that has
affected at least 50 million people around the globe. Considering the severity of the disease …

ABSTRACT Introduction Alzheimer's Disease (AD) represents a large and growing
challenge to patients, carers and healthcare systems, yet extensive efforts to develop …

Introduction: Alzheimer's disease (AD) is a daunting public health threat that has prompted
the scientific community's ongoing efforts to decipher the underlying disease mechanism …

Alzheimer's disease (AD) is the leading cause of dementia worldwide. Clinically, it is
characterized by progressive cognitive impairment and the emergence of neuropsychiatric …

New therapies are needed to combat the symptoms and underlying disease processes in
the dementias. A rapid increase in our understanding of the risk factors for dementia and the …

Introduction: The number of people with dementia, including Alzheimer's disease, is growing
as a result of an ageing global population. Treatments available for AD only alleviate the …

Human clinical trials seek to ameliorate the disease states and symptomatic progression of
illnesses that, as of yet, are largely untreatable according to clinical standards. Ideally …

Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease, and
corresponds to the most common cause of dementia worldwide. Although not fully …

Alzheimer's disease is an age-related progressive neurodegenerative disorder with an
enormous unmet medical need. It is the most common form of dementia affecting∼ 5% of …